AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 22 analysts
Fundamentals
Fundamentals institutional score is 82 using growth durability 81.8.
Valuation
Valuation institutional score is 74 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 45 using mean target upside 7.6%; dispersion penalty 17.8; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 42 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 7 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals and valuation provide support, while analyst consensus and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 0.8% above historical median. Valuation is stable — currently in the fair zone (z-score: +0.23). Confidence: 91%.
Live forward EPS implies next-12-month EPS of ₹12.96. Applying the stock's normalized valuation corridor produces a fair range of ₹613.27 to ₹697.51, with base value near ₹660.96 (+23.6% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹12.96
Forward P/E
41.3x
Base Fair Value
₹660.96
Fair Range
₹613.27 - ₹697.51
Upside To Base
+23.6%
Estimate Source
Live forward EPS
Growth Estimate
+28.5%
5Y Average
50.64
Current
51.39
Overvalued
53.82
Undervalued
47.32
5Y Average
33.38
Current
33.87
Overvalued
35.50
Undervalued
31.12
5Y Average
9.45
Current
9.02
Overvalued
10.19
Undervalued
8.58
Peers & Comparison
Sector: Materials · Theme: Paints
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
ASIAN PAINTS LIMITED ASIANPAINTPaints | +17.9% | 12.8% | 55.0x Premium | +36% vs avg | +11.0% |
GRASIM INDUSTRIES LTD GRASIMCement | +10.5% | 2.8% | 45.5x Fair | +13% vs avg | +23.4% |
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 30.3x Undervalued | -25% vs avg | -5.0% |
HINDALCO INDUSTRIES LTD HINDALCOMetals - Aluminium | +32.1% | 5.5% | 14.2x Undervalued | -65% vs avg | +58.0% |
HERO MOTOCORP LIMITED HEROMOTOCOTwo Wheelers | +34.9% | 10.7% | 21.6x Undervalued | -46% vs avg | +26.2% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.1x Fair | -5% vs avg | +41.0% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 52.5x Premium | +30% vs avg | +51.8% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 65.0x Premium | +61% vs avg | +23.2% |
BERGER PAINTS (I) LTD trades at a premium (51.4x vs peer avg 40.3x), implying higher growth or quality expectations from the Paints cohort. Peers include ASIAN PAINTS LIMITED, GRASIM INDUSTRIES LTD, DR. REDDY S LABORATORIES — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹3.23K CrJun 2026Latest net profit
₹369 CrJun 2026Latest EPS
₹3.16Jun 2026Net margin
17.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 2,740 | 2,440 | 2,574 | 2,249 | 2,806 | 2,431 | 2,585 | 2,347 | 2,863 | 2,458 | 2,595 | 2,504 | 3,227 |
| Expenses + | 2,226 | 2,037 | 2,145 | 1,924 | 2,323 | 2,047 | 2,167 | 1,958 | 2,363 | 2,147 | 2,178 | 2,045 | 2,664 |
| Operating Profit | 514 | 403 | 430 | 325 | 484 | 383 | 417 | 390 | 499 | 311 | 417 | 459 | 562 |
| OPM % | 19% | 17% | 17% | 14% | 17% | 16% | 16% | 17% | 17% | 13% | 16% | 18% | 17% |
| Other Income + | 12 | 16 | 16 | 13 | 17 | 17 | 69 | 19 | -9 | 23 | 56 | 73 | 39 |
| Interest | 17 | 17 | 16 | 15 | 12 | 13 | 12 | 11 | 11 | 14 | 11 | 9 | 10 |
| Depreciation | 70 | 75 | 74 | 78 | 78 | 80 | 80 | 80 | 83 | 86 | 88 | 88 | 91 |
| Profit before tax | 439 | 327 | 355 | 246 | 411 | 308 | 395 | 318 | 396 | 235 | 373 | 434 | 500 |
| Tax % | 26% | 25% | 26% | 26% | 26% | 26% | 22% | 25% | 26% | 25% | 20% | 25% | 26% |
| Net Profit + | 326 | 244 | 263 | 182 | 306 | 229 | 306 | 237 | 294 | 176 | 298 | 327 | 369 |
| EPS in Rs | 2.80 | 2.09 | 2.26 | 1.56 | 2.62 | 1.96 | 2.63 | 2.03 | 2.52 | 1.51 | 2.56 | 2.81 | 3.16 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Earnings Call Transcript